iBio
IBIO
#9842
Rank
NZ$77.12 M
Marketcap
NZ$3.43
Share price
5.32%
Change (1 day)
-17.87%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.67. In 2024 the company made an earnings per share (EPS) of NZ-$11.26 an increase over its 2023 EPS that were of NZ-$183.94.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.63-76.64%
2024NZ-$11.26-93.88%
2023NZ-$183.94-8.14%
2022NZ-$200.2492.67%
2021NZ-$103.93-80.33%
2020NZ-$528.32-35.11%
2019NZ-$814.13-38.96%
2018NZ-$1,334-6.1%
2017NZ-$1,42036.67%
2016NZ-$1,03933.33%
2015NZ-$779.4950%
2014NZ-$519.66-53.85%
2013NZ-$1,126-7.14%
2012NZ-$1,213-64.1%
2011NZ-$3,37877.27%
2010NZ-$1,905144.44%
2009NZ-$779.4912.93%
2008NZ-$690.2612.2%
2007NZ-$615.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.08-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.81 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA